HEALTH TECHNOLOGY

Sense and TECOmedical Sign Distribution Agreement for Germany, Austria, Switzerland

Sense Biodetection | September 02, 2022 | Read time : 03:00 min

Sense and TECOmedical

Global molecular diagnostics innovator, Sense Biodetection announced it has entered into a strategic agreement with TECOmedical for the non-exclusive distribution of Sense’s Veros COVID-19, the first test on the rapid, instrument-free, point-of-care Veros molecular testing platform.

The self-contained, single-use Veros COVID-19 product produces PCR-quality results in about 15 minutes, unconstrained by a reader or need for external power. TECOmedical, a Eurobio Scientific Company, is a leading specialty medical distributor with proven success developing new markets with innovative technology. Effective immediately in Germany and Austria, and pending regulatory approval in Switzerland, the agreement is the latest in Sense’s planned EU distribution partnerships as it commercializes its Veros platform.

“We are delighted to partner with TECOmedical to bring Veros COVID-19 to the market, building on the impressive reputation that TECOmedical has established with their customers,” stated Ryan Roberts, Chief Commercial Officer of Sense. “We’re optimistic that by adding the instrument-free Veros COVID-19 to their diagnostic portfolio, TECOmedical’s customers will be able to take advantage of a laboratory-quality molecular test that can enable improved access and faster diagnosis, helping them to provide exceptional care for their patients right at the point of use.”

We are always looking for innovative technologies that address an unmet need. Being able to offer an instrument free, PCR-quality result in minutes right at the Point of Care reflects our commitment to customers to bring solutions that help them overcome limitations of existing technologies and improve care. We are excited to launch Veros COVID-19 now and are eagerly anticipating an expanded Veros test menu in the future.”

Marieluise Wippermann, CEO of TECOmedical

Veros is the first and only instrument-free, single-use, rapid, point-of-care molecular diagnostic testing platform that produces lab-quality results in about 15 minutes. Using a proprietary, rapid molecular amplification technology, Veros aims to help to improve access to rapid, highly accurate, point of care testing for many more people, and help reduce the spread of COVID-19 with faster, more precise diagnoses.

Veros COVID-19’s clinical performance was established in one of the most comprehensive clinical trials in COVID-19 diagnostic testing conducted to date. The multicentre study prospectively enrolled nearly 300 evaluable subjects during both the Delta and Omicron variant surges of the pandemic. All study sites represented near-patient testing / point-of-care environments, with all test operators reporting no prior formal laboratory training or experience. 100% of operators agreed the Veros COVID-19 was easy-to-use, read and understand the results, with minimal hands-on time required from start to finish.

As the virus continues to evolve, Veros COVID-19 has maintained 100% conservation in all Variants of Interest and Concern identified to date by WHO and the US CDC, including all Omicron sub-variants.

About Sense Biodetection
Sense Biodetection is a global molecular diagnostics company focused on empowering patients and transforming healthcare access and affordability by bringing lab-quality results through easy-to-use, rapid, disposable molecular tests without the constraints of an instrument. The company's Veros product platform will enable widespread testing to enhance patient access, improve patient health and lower systemic healthcare costs. Backed by respected investors, such as Koch Disruptive Technologies, Cambridge Innovation Capital, Earlybird Health and Mercia Asset Management, Sense has launched its first product, Veros COVID-19, and is growing rapidly while building a portfolio of tests for other diseases.

About TECOmedical
The Swiss-based TECOmedical Group, a Eurobio Scientific company, with subsidiaries in Germany and Austria is a leading provider of in-vitro specialty test systems in medical diagnostic, based on Immunosorbent, Immunofluorescence and Molecular methodologies.
 

Spotlight

Today, there are many options for men who have been diagnosed with prostate cancer – from active surveillance to robotic prostatectomies and hormone therapy. We’ll help you sort through the facts of a few of these treatment options.

Spotlight

Today, there are many options for men who have been diagnosed with prostate cancer – from active surveillance to robotic prostatectomies and hormone therapy. We’ll help you sort through the facts of a few of these treatment options.

Related News

FUTURE OF HEALTHCARE

Medimap Partners with Winnipeg Regional Health Authority To Improve Emergency Room Wait Times

Medimap | November 25, 2022

Medimap is pleased to announce it has signed a strategic partnership with the Winnipeg Regional Health Authority to improve patient care and reduce emergency room wait times. The new partnership will make use of Medimap's powerful software technology and its partnerships with a large network of medical clinics in the Winnipeg area by directing Manitobans with low acuity needs to local walk-in clinics. This will help improve Manitobans' access to care by diverting patients with low acuity needs to local medical services that have the capacity to see them, thereby reducing wait times at emergency rooms across the city. "Our new partnership with the Winnipeg Regional Health Authority is a win-win for both patients and the overall healthcare system. Not only will our platform help patients with low acuity needs find the care they need, when they need it, it will also reduce wait times at emergency rooms across the city," Medimap CEO Thomas Jankowski. The partnership means the WRHA will be able to show wait time information at walk-in clinics across the Winnipeg area on hospital screens and its website. The information will allow patients to make informed decisions about where they can get timely access to care. Triage staff will also have immediate access to this information, allowing them to redirect low acuity cases to other healthcare resources. "Every month, approximately 40 percent of people who visit a Winnipeg Urgent Care Centre or emergency department could receive the health care they need, often sooner, through a family doctor or walk-in clinic," said Mike Nader, President and CEO of the Winnipeg Regional Health Authority. "By partnering with Medimap, our goal is to help Manitobans get the timely care they need while reducing the burden on our hospital system. Public-private partnerships like this will help to unlock many of the problems present in our healthcare system." Every month over 250,000 Canadians rely on Medimap as their means of finding same-day, non-urgent access to care. Its software gives clinics the ability to communicate changes in operating hours, or when they are at capacity and also provides the ability for patients to join a waitlist or book an appointment. Patients can quickly check the Medimap website before they travel to a clinic, reducing the length of time they have to wait to see a doctor. Patients can also book appointments with allied health professionals such as physiotherapists, chiropractors, optometrists, mental health services and more. About Medimap Medimap's platform is used by a network of more than 4,200 practices, pharmacies, and walk-in clinics across the country and has helped more than 12 million Canadians find the care they need when they need it. Medimap's platform also provides patients the ability to book appointments with allied health professionals such as physiotherapists, chiropractors, optometrists, mental health services, and more. Not only does this help patients receive timely care, it also helps the healthcare system divert people away from emergency rooms to primary care services that are better suited to their needs, including virtual appointments. About Winnipeg Regional Health Authority The WRHA serves residents of the city of Winnipeg, as well as the northern community of Churchill and the rural municipalities of East and West St. Paul, representing a total population of more than 750,000. The WRHA also provides healthcare support and specialty referral services to nearly half a million Manitobans who live beyond these boundaries, as well as residents of northwestern Ontario and Nunavut, who often require the services and expertise available within the WRHA.

Read More

HEALTH TECHNOLOGY

WELL Health to Acquire EMR, Billing and Clinical Assets from CloudMD

WELL Health Technologies Corp. | October 12, 2022

WELL Health Technologies Corp. a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce it has entered into an agreement to acquire Cloud Practice Inc. and three clinics from CloudMD Software & Services Inc. "This transaction demonstrates our dedication to expanding and strengthening WELL's Canadian healthcare offering through disciplined capital allocation. This acquisition will also enable our EMR and billing divisions to enter new markets in the Canadian Prairies where we look forward to supporting healthcare practitioners' access to new digital health innovations." Hamed Shahbazi, CEO and Founder of WELL Cloud Practice is a medical software application company with products including Juno EMR, a cloud based EMR solution based on OSCAR1, and ClinicAid, a medical billing software used by healthcare practitioners who don't need access to a full EMR. Outside of WELL who is the largest provider of OSCAR1 EMR products and services, Juno EMR represented the largest remaining asset and market share available in the OSCAR1 based EMR industry. Both Juno EMR and ClinicAid represent WELL's entrance into the Alberta and Saskatchewan markets for its EMR and medical billing related lines of business. Both assets will be integrated into WELL's Provider Solutions Business Unit, under WELL's existing EMR and Billing platforms. Amir Javidan, COO of WELL commented, "This transaction is a win for healthcare practitioners and their patients as it will allow software users and clinicians joining our network to have access to WELL's innovative Apps.Health platform which includes dozens of apps designed by leading 3rd party digital health companies providing advanced physician tools such as an AI-powered virtual assistant to premium digital patient engagement tools that can drive significant operating efficiencies for clinics." The three primary care clinics being acquired in the Transaction currently have a total staff of 20 physicians operating out of two clinics in Vancouver, BC and one clinic in Surrey, BC. These clinics are owned by subsidiaries of CloudMD, with all of the shares of these entities being acquired as part of the Transaction. These three clinics will be integrated into WELL's existing primary care clinic network under WELL Health Canada Clinics Inc. About WELL Health Technologies Corp. WELL is a practitioner focused digital healthcare company whose overarching objective is to positively impact health outcomes to empower and support healthcare practitioners and their patients. WELL has built an innovative practitioner enablement platform that includes comprehensive end to end practice management tools inclusive of virtual care and digital patient engagement capabilities as well as Electronic Medical Records (EMR), Revenue Cycle Management (RCM) and data protection services. WELL uses this platform to power healthcare practitioners both inside and outside of WELL's own omni-channel patient services offerings. As such, WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national, multi-disciplinary telehealth offering. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on OTCQX under the symbol "WHTCF".

Read More

HEALTHTECH SECURITY

Carenet Health Acquires Stericycle Communication Solutions, Creating Industry’s Most Comprehensive Healthcare Consumer Engagement Company

Carenet Health | December 02, 2022

Carenet Health, a leading provider of 24/7 and on-demand patient engagement solutions announced it has acquired Stericycle Communication Solutions, an industry leader in patient engagement technology and solutions and a service of Stericycle, Inc. as part of its strategic vision to create a cohesive patient experience and provide better healthcare for all. The acquisition strengthens Carenet’s robust capabilities in the payer, healthcare services, and clinical arenas by adding provider-centric technology services including online scheduling platforms, automated messaging solutions, and additional inbound and outbound call center services. The combined entity provides 1 in 3 Americans access to Carenet offerings and works with 14 of the top 20 health systems in the U.S., among 1,000 other leading healthcare companies. “At this critical moment in healthcare, where health systems are working hard to get patients back in the door for needed procedures, we’re pleased to be able to provide 24/7 modernized and elevated technology tools with the overall goals of better access, better experiences, better outcomes, and better profitability. Carenet is now the industry’s most experienced and comprehensive healthcare consumer engagement company, delivering dynamic integrated solutions that support the ongoing shift to value-based care.” John Erwin, Carenet chief executive officer In addition to Carenet’s Intelligent Engagement™ clinical and telehealth services, Carenet’s offerings now include Best-in-class Intelligent Scheduling solution, built on the InQuicker™ scheduling platform, that enables patients to convert at the moment of intent Broadest and deepest EHR/EMR integrated solution in the marketplace Award-winning SaaS digital and automation platforms with natural language processing and multi-language capabilities Partnerships with leading health-tech innovators, including leading search platforms Fully API-enabled enterprise platform Carenet’s Matt Dickson, formerly senior vice president at Stericycle Communication Solutions, said the deal is a great fit for both companies. “The acquisition creates an enhanced and powerful end-to-end clinical solution for payers, providers, and healthcare partners that eliminates costly handoffs and multi-vendor management headaches,” Dickson said. “Additionally, our hospital and health system customers will continue to receive the top-notch service they expect while also benefiting from Carenet’s deep clinical expertise and resources. The strategic marriage of tech-enabled communications and expert human capital is a recipe for success during this time of worker shortages, delayed care, and heightened interest in non-traditional venues of healthcare.” Carenet’s enhanced portfolio brings together a human touch to patient engagement and innovative technology solutions to deliver meaningful improvements to patient experience and health outcomes while strengthening provider, payer, and healthcare partner successes. “We’re excited to build on our more than 30 years of expertise by exponentially improving our ability to modernize and optimize the delivery of the healthcare consumer experience across the entire patient engagement journey,” said Mick Mazour, Carenet president. “It’s an essential moment in time for healthcare, and we’re well-positioned to answer the industry’s call for better healthcare for all.” About Carenet Health Carenet Health is the industry's leading healthcare consumer engagement company, providing member and patient engagement, clinical support, virtual care, online scheduling, and advocacy solutions for providers, payers, and partners. One in three Americans have access to Carenet's services. The global company is headquartered in San Antonio, Texas. About Stericycle Communication Solutions Stericycle Communication Solutions is an industry leading provider of patient engagement solutions, providing online scheduling, automated messaging, and strategic inbound and outbound call center services to drive patient access, action, and adherence. Combining a human touch with innovative technologies, Stericycle Communication Solutions delivers a comprehensive patient engagement platform that helps clients acquire and retain patients, achieve higher customer satisfaction rates, enhance their brands, and grow revenue.

Read More